Lung epithelial injury markers are not influenced by use of lower tidal volumes during elective surgery in patients without preexisting lung injury

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 294, Issue 2, 2008, Pages

  Determann, Rogier M ^a,b   Wolthuis, Esther K ^a,b   Choi, Goda ^a,b   Bresser, Paul ^a   Bernard, Alfred ^c   Lutter, Rene ^a   Schultz, Marcus J ^a,b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Laboratory of Experimental Intensive Care and Anesthesiology   (Netherlands)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Clara cell protein; Pulmonary inflammation; Receptor for advanced glycation end products

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BIOLOGICAL MARKER; CLARA CELL PROTEIN; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; ELECTIVE SURGERY; FEMALE; HUMAN; INTUBATION; LUNG ALVEOLUS EPITHELIUM; LUNG INJURY; LUNG LAVAGE; MALE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TIDAL VOLUME;

ALBUMINS; ALPHA-GLOBULINS; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; EPITHELIUM; FEMALE; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; PERIOPERATIVE CARE; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; RECEPTORS, IMMUNOLOGIC; SOLUBILITY; SURGICAL PROCEDURES, ELECTIVE; TIDAL VOLUME; UTEROGLOBIN;

EID: 39149096865     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00268.2007     Document Type: Article

References (37)

1. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 342: 1301-1308, 2000.
2. Amato MB, Barbas CS, Medeiros DM, Magaldi RB, Schettino GP, Lorenzi-Filho G, Kairalla RA, Deheinzelin D, Munoz C, Oliveira R, Takagaki TY, Carvalho CR. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 338: 347-354, 1998.
3. Bernard A, Hermans C, Van Houte G. Transient increase of serum Clara cell protein (CC16) after exposure to smoke. Occup Environ Med 54: 63-65, 1997.
4. Bernard A, Lauwerys R, Noel A, Vandeleene B, Lambert A. Determination by latex immunoassay of protein 1 in normal and pathological urine. Clin Chim Acta 201: 231-245, 1991.
5. Bresser P, Out TA, Van Alphen L, Jansen HM, Lutter R. Airway inflammation in nonobstructive and obstructive chronic bronchitis with chronic haemophilus influenzae infection. Comparison with noninfected patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 162: 947-952, 2000.
6. Broeckaert F, Arsalane K, Hermans C, Bergamaschi E, Brustolin A, Mutti A, Bernard A. Serum clara cell protein: a sensitive biomarker of increased lung epithelium permeability caused by ambient ozone. Environ Health Perspect 108: 533-537, 2000.
7. Carney D, DiRocco J, Nieman G. Dynamic alveolar mechanics and ventilator-induced lung injury. Crit Care Med 33, Suppl 3: S122-S128, 2005.
8. Cheng IW, Ware LB, Greene KE, Nuckton TJ, Eisner MD, Matthay MA. Prognostic value of surfactant proteins A and D in patients with acute lung injury. Crit Care Med 31: 20-27, 2003.
9. Choi G, Wolthuis EK, Bresser P, Levi M, van der Poll T, Dzoljic M, Vroom MB, Schultz MJ. Mechanical ventilation with lower tidal volumes and positive end-expiratory pressure prevents alveolar coagulation in patients without acute lung injury. Anesthesiology 105: 689-695, 2006.
10. Decker D, Tolba R, Springer W, Lauschke H, Hirner A, von Ruecker A. Abdominal surgical interventions: local and systemic consequences for the immune system - a prospective study on elective gastrointestinal surgery. J Surg Res 126: 12-18, 2005.
11. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM; Surviving Sepsis Campaign Management Guidelines Committee. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32: 858-873, 2004.
12. Doyle IR, Nicholas TE, Bersten AD. Partitioning lung and plasma proteins: circulating surfactant proteins as biomarkers of alveolocapillary permeability. Clin Exp Pharmacol Physiol 26: 185-197, 1999.
13. Eisner MD, Parsons P, Matthay MA, Ware L, Greene K; Acute Respiratory Distress Syndrome Network. Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury. Thorax 58: 983-988, 2003.
14. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340: 448-454, 1999.
15. Gajic O, Dara SI, Mendez JL, Adesanya AO, Festic E, Caples SM, Rana R, St Sauver JL, Lymp JF, Afessa B, Hubmayr RD. Ventilatorassociated lung injury in patients without acute lung injury at the onset of mechanical ventilation. Crit Care Med 32: 1817-1824, 2004.
16. Gajic O, Frutos-Vivar F, Esteban A, Hubmayr RD, Anzueto A. Ventilator settings as a risk factor for acute respiratory distress syndrome in mechanically ventilated patients. Intensive Care Med 31: 922-926, 2005.
17. Greene KE, Wright JR, Steinberg KP, Ruzinski JT, Caldwell E, Wong WB, Hull W, Whitsett JA, Akino T, Kuroki Y, Nagae H, Hudson LD, Martin TR. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med 160: 1843-1850, 1999.
18. Gunther A, Siebert C, Schmidt R, Ziegler S, Grimminger F, Yabut M, Temmesfeld B, Walmrath D, Morr H, Seeger W. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med 153: 176-184, 1996.
19. Hermans C, Aly O, Nyberg BI, Peterson C, Bernard A. Determinants of Clara cell protein (CC16) concentration in serum: a reassessment with two different immunoassays. Clin Chim Acta 272: 101-110, 1998.
20. Hermans C, Bernard A. Lung epithelium-specific proteins: characteristics and potential applications as markers. Am J Respir Crit Care Med 159: 646-678, 1999.
21. Koner O, Celebi S, Balci H, Cetin G, Karaoglu K, Cakar N. Effects of protective and conventional mechanical ventilation on pulmonary function and systemic cytokine release after cardiopulmonary bypass. Intensive Care Med 30: 620-626, 2004.
22. Lesur O, Hermans C, Chalifour JF, Picotte J, Lévy B, Bernard A, Lane D. Mechanical ventilationi-induced pneumoprotein CC-16 vascular transfer in rats: effect of KGF pretreatment. Am J Physiol Lung Cell Mol Physiol 284: L410-L419, 2003.
23. Lesur O, Langevin S, Berthiaume Y, Legare M, Skrobik Y, Bellemare JF, Levy B, Fortier Y, Lauzier F, Bravo G, Nickmilder M, Rousseau E, Bernard A; Critical Care Research Group of the Quebec Respiratory Health Network. Outcome value of Clara cell protein in serum of patients with acute respiratory distress syndrome. Intensive Care Med 32: 1167-1174, 2006.
24. Michel O, Murdoch R, Bernard A. Inhaled LPS induces blood release of Clara cell specific protein (CC16) in human beings. J Allergy Clin Immunol 115: 1143-1147, 2005.
25. Michelet P, D'Journo XB, Roch A, Doddoli C, Marin V, Papazian L, Decamps I, Bregeon F, Thomas P, Auffray JP. Protective ventilation influences systemic inflammation after esophagectomy: a randomized controlled study. Anesthesiology 105: 911-919, 2006.
26. Ohnishi H, Yokoyama A, Kondo K, Hamada H, Abe M, Nishimura K, Hiwada K, Kohno N. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am J Respir Crit Care Med 165: 378-381, 2002.
27. Out TA, Jansen HM, van Steenwijk RP, de Nooijer MJ, van de Graaf EA, Zuijderhoudt FM. ELISA of ceruloplasmin and alpha-2-macroglobulin in paired bronchoalveolar lavage fluid and serum samples. Clin Chim Acta 165: 277-288, 1987.
28. Pelosi P, Rocco PR. Airway closure: the silent killer of peripheral airways. Crit Care 11: 114-115, 2007.
29. Plotz FB, Slutsky AS, van Vucht AJ, Heijnen CJ. Ventilator-induced lung injury and multiple system organ failure: a critical review of facts and hypotheses. Intensive Care Med 30: 1865-1872, 2004.
30. Schultz MJ, Haitsma JJ, Slutsky AS, Gajic O. What tidal volumes should be used in patients without ALI/ARDS? Anesthesiology 106: 1226-1231, 2007.
31. Schultz MJ, Haitsma JJ, Zhang H, Slutsky AS. Pulmonary coagulopathy as a new target in in therapeutic studies of acute lung injury of pneumonia - a review. Crit Care Med 34: 871-877, 2006.
32. Shimizu H, Hosoda K, Mizumoto M, Kuroki Y, Sato H, Kataoka K, Hagisawa M, Fujimoto S, Akino T. Improved immunoassay for the determination of surfactant protein A (SP-A) in human amniotic fluid. Tohoku J Exp Med 157: 269-278, 1989.
33. Sinclair SE, Kregenow DA, Lamm WJ, Starr IR, Chi EY, Hlastala MP. Hypercapnic acidosis is protective in an in vivo model of ventilator-induced lung injury. Am J Respir Crit Care Med 166: 403-408, 2002.
34. Taskar V, John J, Evander E, Wollmer P, Robertson B, Jonson B. Healthy lungs tolerate repetitive collapse and reopening during short periods of mechanical ventilation. Acta Anaesthesiol Scand 39: 370-376, 1995.
35. Uchida T, Shirasawa M, Ware LB, Kojima K, Hata Y, Makita K, Mednick G, Matthay ZA, Matthay MA. Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med 173: 1008-1015, 2006.
36. Wrigge H, Uhlig U, Baumgarten G, Menzenbach J, Zinserling J, Ernst M, Dromann D, Welz A, Uhlig S, Putensen C. Mechanical ventilation strategies and inflammatory responses to cardiac surgery: a prospective randomized clinical trial. Intensive Care Med 31: 1379-1387, 2005.
37. Wrigge H, Uhlig U, Zinserling J, Behrends-Callsen E, Ottersbach G, Fischer M, Uhlig S, Putensen C. The effects of different ventilatory settings on pulmonary and systemic inflammatory responses during major surgery. Anesth Analg 98: 775-81, 2004.